What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His main research concerns Surgery, Internal medicine, Adenocarcinoma, Pancreas and Cancer.
His Surgery study frequently draws connections between related disciplines such as General surgery.
His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine.
In his research, Prevalence, Epidemiology and Mortality rate is intimately related to Disease, which falls under the overarching field of Gastroenterology.
Peter J. Allen combines subjects such as Cyst, Disease progression, Carcinoma in situ and Serous fluid with his study of Pancreas.
His Cancer research is multidisciplinary, incorporating perspectives in Background data, Gene mutation, Pathology, Lung and Pancreatic disease.
His most cited work include:
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 (6156 citations)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (4452 citations)
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies (2454 citations)
What are the main themes of his work throughout his whole career to date?
Peter J. Allen mainly investigates Surgery, Internal medicine, Oncology, Pancreas and Radiology.
His study in Retrospective cohort study, Hepatectomy, Chemotherapy, Resection and Pancreaticoduodenectomy are all subfields of Surgery.
His Pancreaticoduodenectomy study combines topics in areas such as Perioperative and Pancreatectomy.
His studies link Gastroenterology with Internal medicine.
The Oncology study combines topics in areas such as Survival rate, Prospective cohort study, KRAS and Adjuvant therapy.
His work deals with themes such as Cyst, Dysplasia, Pathology and General surgery, which intersect with Pancreas.
He most often published in these fields:
- Surgery (41.48%)
- Internal medicine (34.47%)
- Oncology (18.94%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (34.47%)
- Surgery (41.48%)
- Radiology (16.86%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Surgery, Radiology, Pancreas and Gastroenterology are his primary areas of study.
His study in Oncology extends to Internal medicine with its themes.
His work in Oncology addresses issues such as Prospective cohort study, which are connected to fields such as Magnetic resonance cholangiopancreatography.
His Pancreas research includes elements of Cyst, Dysplasia, Pathology and General surgery.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Hepatectomy, Disease and Chemotherapy, Phases of clinical research.
His Carcinoma study incorporates themes from Cohort and Adenocarcinoma.
Between 2016 and 2021, his most popular works were:
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula : 11 Years After (1157 citations)
- Detection and localization of surgically resectable cancers with a multi-analyte blood test (908 citations)
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. (407 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Internal medicine, Surgery, Pancreatic cancer, Pancreas and Carcinoma.
His Internal medicine research includes themes of Gastroenterology, Hepatectomy, Antibiotics and Oncology.
His Surgery study combines topics from a wide range of disciplines, such as Pancreatic surgery and Pancreatic fistula.
The study incorporates disciplines such as Cancer research, Malignancy, Adenocarcinoma, Biomarker and Immunotherapy in addition to Pancreatic cancer.
His studies deal with areas such as Survival rate, Clinical trial and Retrospective cohort study as well as Carcinoma.
As part of one scientific family, he deals mainly with the area of Retrospective cohort study, narrowing it down to issues related to the Radiology, and often Cancer, Nomogram and Pancreatic tumor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
